Bio Special BioInvest
Syneron Bio Enters $3.5B Strategic Collaboration with AstraZeneca to Develop Novel Macrocyclic Peptide Therapies
Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical lead...
March 24, 2025 | News
C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing
-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...
March 14, 2025 | News
Insilico Medicine Secures $110M Series E to Advance AI-Powered Drug Discovery and Clinical Innovations
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully s...
March 14, 2025 | News
SPRIM Global Investments and OneIM Launch $300M Joint Venture to Accelerate Clinical Trial Financing
SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and On...
March 11, 2025 | News
Health2Sync Secures Over $20M in Series C Funding to Drive Global Expansion and AI-Driven Chronic Disease Management
Health2Sync (H2), a leading digital health company specializing in chronic disease management, today announced it has raised over US$20 million in a Series...
March 05, 2025 | News
MojiaBio and A*STAR Partner to Develop SGD 44.8 Million Sustainable Biomanufacturing Technology Platform in Singapore
MojiaBio, a global leader in green chemistry and sustainable biomanufacturing, has announced a strategic partnership with the Agency for Science, Technolog...
March 03, 2025 | News
Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine
The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...
February 27, 2025 | News
CARsgen Therapeutics and Zhuhai SB Xinchuang Partner to Advance Allogeneic CAR-T Therapies in China
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
February 26, 2025 | News
Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration
The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...
February 17, 2025 | News
Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders
Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, anno...
February 17, 2025 | News
GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply
New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the en...
February 03, 2025 | News
GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...
January 30, 2025 | News
AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL...
January 28, 2025 | News
Beckman Coulter and Indiana University School of Medicine Secure $2.5M Grant to Enhance Leukemia and Lymphoma Testing in Western Kenya
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been awa...
January 22, 2025 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
